Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
It works by targeting the receptors of glucagon-like peptide-1 (GLP-1), a gut hormone involved in regulating your digestion, appetite, and blood sugar levels
A February 2024 MarketWatch report projects a staggering growth rate of more than 20% annually, with the GLP-1 market set to reach a whopping $133 billion worldwide by 2030
This dual-action approach allows Tirzepatide to not only regulate blood sugar levels but also enhance weight loss significantly
Research from the SURMOUNT and STEP trials showed that up to 40 percent of the weight lost on GLP-1 medications can come from lean mass (muscle), not fat
A study on rodents supported the involvement of Ochratoxin A mycotoxin in developing breast cancer through genetic damage, and the study hypothesized the possibility of the Ochratoxin A in causing breast cancer
In brief, the protocol consists of the following steps: (1) generation of flexible regions in FOXO4 FH (residues 86-104 and 186-207), the p53 TAD2 peptide, and spin labels, randomization of the flexible regions
US$ 29.31
US$ 27.58
US$ 25.02
US$ 29.09
US$ 27.01
US$ 22.74
US$ 25.93
US$ 20.82
US$ 24.81
